BLCM - Bellicum Pharma Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 NIO (1.53%) BA (0.05%) CCL (0%) WKHS (0%) CAT (0%) BLDR (0%) BHC (0%) AMD (0%) AAPL (-1.60%) AAL (-1.24%) MGEN (0%) MCD (0%) LMND (0%) LEN (0%) KR (0%) JMIA (0%) INO (0%) GH (0%) GFI (0%) GE (0%) FDX (0%) ERIE (0%) EDU (0%) EBON (0%) DIS (0%)

BLCM - Bellicum Pharmaceuti...

$6.90 0[0%]

15 mins delayed data

People also watch : ALDX | TTOO

+Watchlist

5 StockHoot Traders following this.
Analyst Ratings | Earnings

Previous Close	$6.90	Open
Volume		Market Cap	93.86M
Yield		Last Dividend

Day

52 Week

Here is What Hedge Funds Think About Bel...	06/12/20
In this article you are going to find out whether hedge funds think Bellicum Pharmaceuticals Inc (NASDAQ:BLCM) is a good investment right now. We like...

All You Need to Know About Bellicum Phar...	05/22/20
Bellicum Pharmaceuticals (BLCM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank ...

The Daily Biotech Pulse: Roche Obtains F...	03/13/20
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 12.) ...

The Daily Biotech Pulse: NY State Endors...	03/11/20
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 10)...

The Daily Biotech Pulse: Mesoblast To Te...	03/10/20
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 9.) A...

Bellicum Pharmaceuticals to Present New ...	01/16/20
HOUSTON, Jan. 16, 2020 -- Bellicum Pharmaceuticals, Inc. , a leader in developing novel, controllable cellular immunotherapies for cancers, today anno...

Short Interest in Bellicum Pharmaceutica...	11/16/19
Bellicum Pharmaceuticals Inc (NASDAQ:BLCM) was the recipient of a significant growth in short interest during the month of October. As of October 31st...

Earnings Preview: Bellicum Pharmaceutica...	10/29/19
Bellicum Pharmaceuticals (BLCM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Ge...

The Daily Biotech Pulse: Roche Snags Dou...	08/16/19
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 15) ...

The Daily Biotech Pulse: Glaukos To Buy ...	08/08/19
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 7) A...

The Daily Biotech Pulse: Novartis Stands...	08/07/19
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 6) A...

The Daily Biotech Pulse: Sanofi's Dupixe...	08/06/19
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks No biotech stocks hit 52-week highs Monday. Down I...

The Daily Biotech Pulse: Jounce Jumps On...	07/24/19
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 23) ...

The Daily Biotech Pulse: Vertex Bets Big...	06/07/19
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on June 6) B...

Bellicum Pharmaceuticals (BLCM) May Repo...	05/07/19
Bellicum Pharmaceuticals (BLCM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Ge...

Bellicum Pharmaceuticals beats by $0.03,...	05/07/19
Bellicum Pharmaceuticals (BLCM): Q1 GAAP EPS of -$0.55 beats by $0.03. Revenue of $0.52M (+246.7% Y/Y) beats by $0.34M. Press Release

Bellicum Pharmaceuticals, Inc.'s (BLCM) ...	03/12/19
No summary available.

Bellicum Pharmaceuticals beats by $0.02,...	03/12/19
No summary available.

FDA finalizes guidance for expedited rev...	02/15/19
No summary available.

Oncology players in the red on Celgene d...	01/03/19
No summary available.

Oncology players in the red on Celgene d...	01/03/19
No summary available.

ANALYST RATINGS

0 analyst ratings (Last 3 months)

0.00 %

Strong Buy + Buy

Price Target (PT)

EARNINGS

Date	2020-08-06 (AMC)	Est. (EPS/Rev.)	($3.33)/ 900K
Actual (EPS/Rev.)	$-7.81/	EPS (TTM)	0

TRADERS TRACKING $BLCM

Service Name	Trader	% Success
Mojo Day Trading	ProTrader Mike	46.00 %	Subscribe

SHOW ALL TRADERS

About Us

Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.

Product Types

Strategies

Follow Us

Secure Payments

We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.